OFIX - Orthofix Medical Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
53.58
+0.02 (+0.04%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close53.56
Open53.96
Bid53.54 x 3200
Ask53.61 x 1100
Day's Range52.93 - 54.00
52 Week Range47.79 - 74.44
Volume74,634
Avg. Volume135,170
Market Cap1.022B
Beta (3Y Monthly)0.69
PE Ratio (TTM)107.37
EPS (TTM)0.50
Earnings DateAug 6, 2018 - Aug 10, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est75.38
Trade prices are not sourced from all markets
  • Orthofix Medical (OFIX) Beats on Q2 Earnings, Margins Down
    Zacks

    Orthofix Medical (OFIX) Beats on Q2 Earnings, Margins Down

    Orthofix Medical's (OFIX) Q2 performance across all business segments has been commendable, except for spinal implants.

  • Orthofix Medical Inc (OFIX) Q2 2019 Earnings Call Transcript
    Motley Fool

    Orthofix Medical Inc (OFIX) Q2 2019 Earnings Call Transcript

    OFIX earnings call for the period ending June 30, 2019.

  • Orthofix (OFIX) Q2 Earnings Miss Estimates
    Zacks

    Orthofix (OFIX) Q2 Earnings Miss Estimates

    Orthofix (OFIX) delivered earnings and revenue surprises of -30.00% and 0.13%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Orthofix Names Jon Serbousek to Succeed CEO
    Business Wire

    Orthofix Names Jon Serbousek to Succeed CEO

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it has named Jon Serbousek as President of its Global Spine business effective August 5, 2019, and the successor to Brad Mason, the company’s retiring President and Chief Executive Officer (CEO), to be effective November 1, 2019.

  • Business Wire

    Orthofix Reports Second Quarter 2019 Results

    LEWISVILLE, Texas-- -- Jon Serbousek to succeed Brad Mason as President and Chief Executive Officer on November 1, 2019 Net sales of $115.9 million, an increase of 3.9% compared to prior year and 5.0% on a constant currency basis Biologics products net sales increased 14.2% and now has #1 market share position within its segment 1 $500,000 in US M6-C cervical disc sales since June 1 Company reiterates ...

  • ACCESSWIRE

    Orthofix Medical, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 5, 2019 / Orthofix Medical, Inc. (NASDAQ: OFIX ) will be discussing their earnings results in their 2019 Second Quarter Earnings to be held on August 5, 2019 at 4:30:PM ...

  • Earnings Preview: Orthofix (OFIX) Q2 Earnings Expected to Decline
    Zacks

    Earnings Preview: Orthofix (OFIX) Q2 Earnings Expected to Decline

    Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

  • Business Wire

    Orthofix Schedules Second Quarter 2019 Earnings Release and Conference Call for August 5, 2019

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the second quarter 2019 after market close on Monday, August 5, 2019. Brad Mason, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing (844) 809-1992 in the U.S. and (612) 979-9886 outside the U.S., and referencing the conference ID 1534617.

  • Shareholders Should Look Hard At Orthofix Medical Inc.’s (NASDAQ:OFIX) 7.1% Return On Capital
    Simply Wall St.

    Shareholders Should Look Hard At Orthofix Medical Inc.’s (NASDAQ:OFIX) 7.1% Return On Capital

    Today we are going to look at Orthofix Medical Inc. (NASDAQ:OFIX) to see whether it might be an attractive investment...

  • Will MedTech Ease Investors' Concern & Outperform? 4 Picks
    Zacks

    Will MedTech Ease Investors' Concern & Outperform? 4 Picks

    Lower investment in MedTech might prove to be a concern, more so as gains within this space are staggering.

  • Is Orthofix Medical Inc. (NASDAQ:OFIX) Trading At A 26% Discount?
    Simply Wall St.

    Is Orthofix Medical Inc. (NASDAQ:OFIX) Trading At A 26% Discount?

    In this article we are going to estimate the intrinsic value of Orthofix Medical Inc. (NASDAQ:OFIX) by projecting its...

  • Is There An Opportunity With Orthofix Medical Inc.'s (NASDAQ:OFIX) 26% Undervaluation?
    Simply Wall St.

    Is There An Opportunity With Orthofix Medical Inc.'s (NASDAQ:OFIX) 26% Undervaluation?

    Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Orthofix Medical Inc...

  • Is Orthofix Medical Inc.'s (NASDAQ:OFIX) CEO Paid Enough Relative To Peers?
    Simply Wall St.

    Is Orthofix Medical Inc.'s (NASDAQ:OFIX) CEO Paid Enough Relative To Peers?

    In 2013 Brad Mason was appointed CEO of Orthofix Medical Inc. (NASDAQ:OFIX). This analysis aims first to contrast CEO...

  • Is Orthofix Medical Inc. (OFIX) A Good Stock To Buy?
    Insider Monkey

    Is Orthofix Medical Inc. (OFIX) A Good Stock To Buy?

    Insider Monkey finished processing more than 738 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2019. What do these smart investors think about Orthofix Medical Inc. (NASDAQ:OFIX)? Is Orthofix Medical Inc. (NASDAQ:OFIX) a healthy stock for your portfolio? Prominent investors are getting more optimistic. The […]

  • Business Wire

    Orthofix to Present at Jefferies 2019 Healthcare Conference

    Orthofix Medical Inc. , a global medical device company focused on musculoskeletal products and therapies, today announced that President and Chief Executive Officer Brad Mason will present at the Jefferies 2019 Healthcare Conference in New York on Thursday, June 6, 2019 at 1:30 p.m.

  • Orthofix Medical Inc (OFIX) Q1 2019 Earnings Call Transcript
    Motley Fool

    Orthofix Medical Inc (OFIX) Q1 2019 Earnings Call Transcript

    OFIX earnings call for the period ending March 31, 2019.

  • Orthofix (OFIX) Misses Q1 Earnings and Revenue Estimates
    Zacks

    Orthofix (OFIX) Misses Q1 Earnings and Revenue Estimates

    Orthofix (OFIX) delivered earnings and revenue surprises of -32.50% and -1.73%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

  • Associated Press

    Orthofix: 1Q Earnings Snapshot

    The Lewisville, Texas-based company said it had net income of 5 cents per share. Earnings, adjusted for one-time gains and costs, came to 27 cents per share. The medical device maker posted revenue of ...

  • Business Wire

    Orthofix Reports First Quarter 2019 Results

    LEWISVILLE, Texas-- -- Net sales of $109.1 million, an increase of 0.4% compared to prior year and 1.9% on a constant currency basis Biologics products net sales increased 16.6% excluding the contractual reduction in marketing services fee Net income of $0.9 million; compared to net income of $5.2 million in the prior year Adjusted EBITDA of $15.7 million; a decrease of $4.1 million, or 20.5%, compared ...

  • Here’s What Hedge Funds Think About Orthofix Medical Inc. (OFIX)
    Insider Monkey

    Here’s What Hedge Funds Think About Orthofix Medical Inc. (OFIX)

    After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed those firms' equity portfolios as of December 31. The results of that effort will be put on display in this article, as […]

  • Orthofix Medical Inc. (NASDAQ:OFIX): What Are The Future Prospects?
    Simply Wall St.

    Orthofix Medical Inc. (NASDAQ:OFIX): What Are The Future Prospects?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Orthofix Medical Inc.'s (NASDAQ:OFIX) latest earnings announcement in December 2018 confirmed...

  • Business Wire

    Orthofix Schedules First Quarter 2019 Earnings Release and Conference Call for May 6, 2019

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the first quarter 2019 after market close on Monday, May 6, 2019. Brad Mason, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 4:30 p.m. ET the same day. Interested parties may access the conference call by dialing (844) 809-1992 in the U.S. and (612) 979-9886 outside the U.S., and referencing the conference ID 3049899.

  • Orthofix Announces First US Patient Implants Following FDA Approval of the M6-C Artificial Cervical Disc Designed to Treat Cervical Disc Degeneration
    Business Wire

    Orthofix Announces First US Patient Implants Following FDA Approval of the M6-C Artificial Cervical Disc Designed to Treat Cervical Disc Degeneration

    Orthofix Medical Inc. (OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced the first commercial implants of patients with the M6-C™ artificial cervical disc. The Center for Disc Replacement at Texas Back Institute (TBI) in Dallas, Texas recently implanted four patients suffering from single level cervical disc degeneration with the newly approved M6-C disc -- a next-generation artificial disc developed to replace an intervertebral disc damaged by cervical disc degeneration. Designed with an artificial viscoelastic nucleus and fiber annulus that mimics the anatomic structure of a natural disc, the M6-C device is the only artificial cervical disc available in the U.S. that enables compression or “shock absorption” at the implanted level.

  • A Closer Look At Orthofix Medical Inc.'s (NASDAQ:OFIX) Uninspiring ROE
    Simply Wall St.

    A Closer Look At Orthofix Medical Inc.'s (NASDAQ:OFIX) Uninspiring ROE

    Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for th...